Clinical Trial

Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases

Recruiting
View on ClinicalTrials.gov →
Summary
FAP-targeted PET imaging using 68Ga-FAPI enables early detection of myocardial fibrosis. Combined PET/CMR provides comprehensive cardiac assessment without extra radiation. This advanced imaging approach improves diagnosis and personalized treatment for better patient outcomes.
Trial Details
NCT Number NCT07063043
Lead Sponsor Shanghai East Hospital
Conditions Cardiovascular Diseases (CVD)
Enrollment 40 participants
Start Date 2024-12-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-14